Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Contribution of dfrA and inhA Mutations to the Detection of Isoniazid-Resistant Mycobacterium tuberculosis Isolates

Yu Min Ho, Yong-Jiang Sun, Sin-Yew Wong, Ann S. G. Lee
Yu Min Ho
1Division of Medical Sciences, National Cancer Centre, Singapore 169610
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong-Jiang Sun
2Department of Infectious Disease, Tan Tock Seng Hospital, Singapore 308433
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sin-Yew Wong
2Department of Infectious Disease, Tan Tock Seng Hospital, Singapore 308433
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann S. G. Lee
1Division of Medical Sciences, National Cancer Centre, Singapore 169610
3Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dmslsg@nccs.com.sg
DOI: 10.1128/AAC.00433-09
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Screening of 127 isoniazid (INH)-resistant Mycobacterium tuberculosis isolates from Singapore for mutations within the dfrA and inhA genes revealed mutations in 0 and 5 (3.9%) isolates respectively, implying that mutations in dfrA do not contribute to the detection of INH-resistant M. tuberculosis and that mutations within inhA are rare. Thirty-seven (29%) of the 127 isolates had no mutations in any of the genes implicated in INH resistance (katG, kasA, and ndh; inhA and ahpC promoters), suggesting that there are new INH targets yet to be discovered.

Mycobacterium tuberculosis remains a major health concern worldwide, with approximately 2 billion people currently infected worldwide and 9.2 million new cases in 2006 (13, 27). The emergence of multidrug-resistant tuberculosis has increased global efforts to understand the molecular mechanisms of drug resistance in M. tuberculosis.

Isoniazid (INH) for M. tuberculosis chemotherapy has always been used as first-line treatment (25) since it was found to exhibit powerful bactericidal activity against the disease by effectively causing loss of acid fastness in M. tuberculosis through inhibition of mycolic acid synthesis (9). However, its widespread use, justified by its high specificity, low cost, and considerably low toxicity, has seen treatment failures due to increasing resistance to the drug.

Clinical resistance to INH is widely known to be caused by mutations within the katG and inhA genes and the promoter region of inhA (2, 13, 18, 19, 25, 29). Other genes, such as kasA and ndh, have been implicated in INH resistance, but mutations in these genes are rare and have been observed in INH-susceptible isolates and/or in association with katG mutations (8, 11, 12, 14, 15, 18, 25, 28). The ahpC gene is involved in the cellular regulation of oxidative stress (18, 22). Mutations within the oxyR-ahpC intergenic region that result in increased expression of alkyl hydroperoxidase are considered to compensate for peroxide sensitivity due to loss of KatG function found in clinical resistant strains (10, 22, 28). Nevertheless, screening of INH-resistant clinical isolates of M. tuberculosis for mutations within kasA, ndh, and ahpC is often performed.

We have previously extensively characterized INH-resistant isolates for mutations within all of these regions; however, 57 (36%) of 160 INH-resistant isolates from Singapore had no detectable alterations (11, 12). This finding suggests that mutations in other genes that confer resistance to INH may exist.

Recently, dihydrofolate reductase, encoded by the dfrA gene, was proposed as a new target for INH (1) as it has been reported that NADP-bound INH had been shown to inhibit dihydrofolate reductase, an enzyme essential for nucleic acid synthesis. Also, the importance of mutations within the structural region of enoyl reductase (InhA), encoded by the inhA gene, have been reported where a single point mutation allele (S94A) transferred by using specialized linkage transduction was able to confer clinically relevant levels of resistance and inhibit mycolic acid synthesis (18, 26). Most studies investigating mutations in the inhA gene analyzed the promoter region of inhA and not the region within the gene (6-8, 16, 17). Thus, we aimed to screen for mutations within both the inhA and dfrA genes of INH-resistant M. tuberculosis isolates to determine whether mutations within these genes contribute to INH resistance.

A total of 127 INH-resistant clinical isolates and 15 INH-sensitive isolates from Singapore were included in this study in order to gain molecular insight into INH resistance. DNA extracted from the isolates was analyzed by amplifying two overlapping fragments for the entire inhA gene and one fragment for the entire dfrA gene (Table 1). Amplification of the genes through PCR was done by using specific oligonucleotide primers for the respective gene fragments (Table 1). PCR products were purified (NucleoSpin Extract Column II; Macherey-Nagel) and directly sequenced with the BigDye Terminator sequencing kit V3.1 (Applied Biosystems), followed by analysis on the 3130XL Genetic Analyzer (Applied Biosystems). Confirmation of mutations was done by reamplification and resequencing. The nucleotide sequences obtained were aligned against the reference sequences of the respective genes of M. tuberculosis reference strain H37Rv by using the DNASTAR SeqMan II software (Lasergene).

Screening of the entire inhA gene revealed mutations in five (3.9%) of 127 INH-resistant isolates (synonymous mutation GGA→GGC at nucleotide position 9 or G3G [n = 2], I21T [n = 2], or I194T [n = 1]). Of the five isolates with mutations, four also had mutations in the ahpC promoter, the inhA promoter, and the kasA gene, which were detected in our previous study (Table 2) (11). Such an occurrence might suggest that some of the observed substitutions are not unique mutations that actually contribute to INH resistance. Also, the low mutational frequency within the inhA gene among INH-resistant isolates suggests this (11). Furthermore, a previous study reported that a previously known mutation, at position 491 of the rrs gene, was in fact a polymorphism within the F11 family and not actually involved in streptomycin resistance (24). Hence, mutations found, especially rarely occurring ones, should not be hastily perceived to confer resistance.

Screening of the entire dfrA gene did not reveal any mutations in any of the 127 INH-resistant isolates, suggesting that dfrA mutations may not contribute to INH resistance and that screening for dfrA mutations in INH-resistant isolates is unnecessary.

To determine if the mutations detected within the inhA gene are mutations and not polymorphisms, we screened 15 INH-susceptible isolates and found no mutations in inhA. These isolates also did not have mutations in the dfrA gene.

Mutations at both I21T (3, 5, 18) and I194T (5, 13) were previously reported to confer resistance to INH. Ile21 and Ile194 were shown to be 2 of the 10 most important amino acid residues making conserved hydrogen bonds with NADH cofactor in the wild-type InhA protein, which encourages INH sensitivity (21). Amino acid replacements will result in lowered NADH affinity and therefore confer resistance to INH since InhA inactivation is dependent on the presence of bound NADH (4, 13, 20, 23, 28).

Of the 127 INH-resistant samples we have screened, there remain 37 samples (29%) with no mutations in any of the genes reported to be involved in INH resistance. This possibly implies that there are new INH targets yet to be discovered. Our findings suggest that mutations in dfrA do not contribute to the detection of INH-resistant M. tuberculosis and that mutations within the inhA gene are rare.

View this table:
  • View inline
  • View popup
TABLE 1.

Oligonucleotide primers used for the amplification of the entire dfrAa and inhAb genes

View this table:
  • View inline
  • View popup
TABLE 2.

M. tuberculosis isolates with mutations in the inhA gene

ACKNOWLEDGMENTS

We acknowledge the Central Tuberculosis Laboratory, Department of Pathology, Singapore General Hospital, for providing isolates.

This work was funded by a Singhealth Cluster Research Grant (SHF/FG346P/2006).

FOOTNOTES

    • Received 31 March 2009.
    • Returned for modification 28 April 2009.
    • Accepted 25 June 2009.
  • Copyright © 2009 American Society for Microbiology

REFERENCES

  1. 1.↵
    Argyrou, A., M. W. Vetting, B. Aladegbami, and J. S. Blanchard. 2006. Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid. Nat. Struct. Mol. Biol.13:408-413.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, K. S. Um, T. Wilson, D. Collins, G. de Lisle, and W. R. Jacobs, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science263:227-230.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Basso, L. A., and J. S. Blanchard. 1998. Resistance to antitubercular drugs. Adv. Exp. Med. Biol.456:115-144.
    OpenUrlPubMed
  4. 4.↵
    Basso, L. A., R. Zheng, J. M. Musser, W. R. Jacobs, Jr., and J. S. Blanchard. 1998. Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates. J. Infect. Dis.178:769-775.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    Brossier, F., N. Veziris, C. Truffot-Pernot, V. Jarlier, and W. Sougakoff. 2006. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. J. Clin. Microbiol.44:3659-3664.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Caws, M., P. M. Duy, D. Q. Tho, N. T. Lan, D. V. Hoa, and J. Farrar. 2006. Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J. Clin. Microbiol.44:2333-2337.
    OpenUrlAbstract/FREE Full Text
  7. 7.
    Guo, H., Q. Seet, S. Denkin, L. Parsons, and Y. Zhang. 2006. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA. J. Med. Microbiol.55:1527-1531.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    Hazbón, M. H., M. Brimacombe, M. Bobadilla del Valle, M. Cavatore, M. I. Guerrero, M. Varma-Basil, H. Billman-Jacobe, C. Lavender, J. Fyfe, L. Garcia-Garcia, C. I. Leon, M. Bose, F. Chaves, M. Murray, K. D. Eisenach, J. Sifuentes-Osornio, M. D. Cave, A. Ponce de Leon, and D. Alland. 2006. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother.50:2640-2649.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Johnson, R., E. M. Streicher, G. E. Louw, R. M. Warren, P. D. van Helden, and T. C. Victor. 2006. Drug resistance in Mycobacterium tuberculosis. Curr. Issues Mol. Biol.8:97-111.
    OpenUrlPubMedWeb of Science
  10. 10.↵
    Kelley, C. L., D. A. Rouse, and S. L. Morris. 1997. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother.41:2057-2058.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Lee, A. S., I. H. Lim, L. L. Tang, A. Telenti, and S. Y. Wong. 1999. Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrob. Agents Chemother.43:2087-2089.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Lee, A. S., A. S. Teo, and S. Y. Wong. 2001. Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother.45:2157-2159.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Leung, E. T., P. L. Ho, K. Y. Yuen, W. L. Woo, T. H. Lam, R. Y. Kao, W. H. Seto, and W. C. Yam. 2006. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA. Antimicrob. Agents Chemother.50:1075-1078.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Mdluli, K., R. A. Slayden, Y. Zhu, S. Ramaswamy, X. Pan, D. Mead, D. D. Crane, J. M. Musser, and C. E. Barry III. 1998. Inhibition of a Mycobacterium tuberculosis β-ketoacyl ACP synthase by isoniazid. Science280:1607-1610.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    Miesel, L., T. R. Weisbrod, J. A. Marcinkeviciene, R. Bittman, and W. R. Jacobs, Jr. 1998. NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis. J. Bacteriol.180:2459-2467.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    Morris, S., G. H. Bai, P. Suffys, L. Portillo-Gomez, M. Fairchok, and D. Rouse. 1995. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J. Infect. Dis.171:954-960.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    Park, H., E. J. Song, E. S. Song, E. Y. Lee, C. M. Kim, S. H. Jeong, J. H. Shin, J. Jeong, S. Kim, Y. K. Park, G. H. Bai, and C. L. Chang. 2006. Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates. J. Clin. Microbiol.44:1619-1624.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    Ramaswamy, S., and J. M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis.79:3-29.
    OpenUrlCrossRefPubMed
  19. 19.↵
    Rouse, D. A., Z. Li, G. H. Bai, and S. L. Morris. 1995. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother.39:2472-2477.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    Rozwarski, D. A., G. A. Grant, D. H. Barton, W. R. Jacobs, Jr., and J. C. Sacchettini. 1998. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science279:98-102.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    Schroeder, E. K., L. A. Basso, D. S. Santos, and O. N. de Souza. 2005. Molecular dynamics simulation studies of the wild-type, I21V, and I16T mutants of isoniazid-resistant Mycobacterium tuberculosis enoyl reductase (InhA) in complex with NADH: toward the understanding of NADH-InhA different affinities. Biophys. J.89:876-884.
    OpenUrlCrossRefPubMed
  22. 22.↵
    Sherman, D. R., K. Mdluli, M. J. Hickey, T. M. Arain, S. L. Morris, C. E. Barry III, and C. K. Stover. 1996. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science272:1641-1643.
    OpenUrlAbstract
  23. 23.↵
    Telenti, A., N. Honore, C. Bernasconi, J. March, A. Ortega, B. Heym, H. E. Takiff, and S. T. Cole. 1997. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol.35:719-723.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    Victor, T. C., A. van Rie, A. M. Jordaan, M. Richardson, G. D. van Der Spuy, N. Beyers, P. D. van Helden, and R. Warren. 2001. Sequence polymorphism in the rrs gene of Mycobacterium tuberculosis is deeply rooted within an evolutionary clade and is not associated with streptomycin resistance. J. Clin. Microbiol.39:4184-4186.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    Vilchèze, C., and W. R. Jacobs, Jr. 2007. The mechanism of isoniazid killing: clarity through the scope of genetics. Annu. Rev. Microbiol.61:35-50.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    Vilchèze, C., F. Wang, M. Arai, M. H. Hazbon, R. Colangeli, L. Kremer, T. R. Weisbrod, D. Alland, J. C. Sacchettini, and W. R. Jacobs, Jr. 2006. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat. Med.12:1027-1029.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    World Health Organization. 2008, posting date. Global tuberculosis control: surveillance, planning, financing. World Health Organization, Geneva, Switzerland. http://www.who.int/tb/publications/global_report/2008/pdf/full_report.pdf .
  28. 28.↵
    Zhang, M., J. Yue, Y. P. Yang, H. M. Zhang, J. Q. Lei, R. L. Jin, X. L. Zhang, and H. H. Wang. 2005. Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J. Clin. Microbiol.43:5477-5482.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature358:591-593.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Contribution of dfrA and inhA Mutations to the Detection of Isoniazid-Resistant Mycobacterium tuberculosis Isolates
Yu Min Ho, Yong-Jiang Sun, Sin-Yew Wong, Ann S. G. Lee
Antimicrobial Agents and Chemotherapy Aug 2009, 53 (9) 4010-4012; DOI: 10.1128/AAC.00433-09

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Contribution of dfrA and inhA Mutations to the Detection of Isoniazid-Resistant Mycobacterium tuberculosis Isolates
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Contribution of dfrA and inhA Mutations to the Detection of Isoniazid-Resistant Mycobacterium tuberculosis Isolates
Yu Min Ho, Yong-Jiang Sun, Sin-Yew Wong, Ann S. G. Lee
Antimicrobial Agents and Chemotherapy Aug 2009, 53 (9) 4010-4012; DOI: 10.1128/AAC.00433-09
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

antitubercular agents
Bacterial Proteins
Drug Resistance, Bacterial
isoniazid
Mycobacterium tuberculosis
Oxidoreductases

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596